Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies.
about
Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next StepSignal transduction of platelet-induced liver regeneration and decrease of liver fibrosisNEDD9/Arf6-dependent endocytic trafficking of matrix metalloproteinase 14: a novel mechanism for blocking mesenchymal cell invasion and metastasis of breast cancer.MMP mediated degradation of type VI collagen is highly associated with liver fibrosis--identification and validation of a novel biochemical marker assayNew insight into the antifibrotic effects of praziquantel on mice in infection with Schistosoma japonicumNovel functions of platelets in the liver.Honokiol Alleviates Hypertrophic Scar by Targeting Transforming Growth Factor-β/Smad2/3 Signaling Pathway.Low transformation growth factor-β1 production and collagen synthesis correlate with the lack of hepatic periportal fibrosis development in undernourished mice infected with Schistosoma mansoni.Synthesis and anti-obesity effects in vivo of Crotadihydrofuran C as a novel PPARγ antagonist from Crotalaria albidaBroad-spectrum matrix metalloproteinase inhibition curbs inflammation and liver injury but aggravates experimental liver fibrosis in miceDeleterious effect of oltipraz on extrahepatic cholestasis in bile duct-ligated mice.Preventing tissue fibrosis by local biomaterials interfacing of specific cryptic extracellular matrix information.Anchoring hepatic gene expression with development of fibrosis and neoplasia in a toxicant-induced fish model of liver injuryHepatocyte produced matrix metalloproteinases are regulated by CD147 in liver fibrogenesisMediators leading to fibrosis - how to measure and control them in tissue engineering.Relaxin regulates MMP expression and promotes satellite cell mobilization during muscle healing in both young and aged mice.Protective effects of Antrodia cinnamomea against liver injury.Phosphodiesterase inhibition mediates matrix metalloproteinase activity and the level of collagen degradation fragments in a liver fibrosis ex vivo rat model.Truncated active human matrix metalloproteinase-8 delivered by a chimeric adenovirus-hepatitis B virus vector ameliorates rat liver cirrhosis.Antifibrotic effect of MMP13-encoding plasmid DNA delivered using polyethylenimine shielded with hyaluronic acidCD44 plays a critical role in regulating diet-induced adipose inflammation, hepatic steatosis, and insulin resistanceSerum proteome profiling identifies novel and powerful markers of cystic fibrosis liver diseaseTissue inhibitor of metalloproteinase 1 (TIMP-1) deficiency exacerbates carbon tetrachloride-induced liver injury and fibrosis in mice: involvement of hepatocyte STAT3 in TIMP-1 productionTonsil-derived mesenchymal stem cells ameliorate CCl4-induced liver fibrosis in mice via autophagy activationMacrophage migration inhibitory factor is required for recruitment of scar-associated macrophages during liver fibrosis.Assessment of proteolytic degradation of the basement membrane: a fragment of type IV collagen as a biochemical marker for liver fibrosis.Novel insights into the function and dynamics of extracellular matrix in liver fibrosis.MT1-MMP regulates the turnover and endocytosis of extracellular matrix fibronectinMatrix metalloproteinases in liver injury, repair and fibrosis.Efficacy of Dietary Lipid Control in Healing High-Fat and High-Cholesterol Diet-Induced Fibrotic Steatohepatitis in Rats.Oxymatrine liposome attenuates hepatic fibrosis via targeting hepatic stellate cells.Circulating levels of citrullinated and MMP-degraded vimentin (VICM) in liver fibrosis related pathologyAtherofibrosis - a unique and common process of the disease pathogenesis of atherosclerosis and fibrosis - lessons for biomarker developmentOleoylethanolamide, an endogenous PPAR-α ligand, attenuates liver fibrosis targeting hepatic stellate cells.Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure.New Mechanism of Hepatic Fibrogenesis: Hepatitis C Virus Infection Induces Transforming Growth Factor β1 Production through Glucose-Regulated Protein 94.Loss of steroid receptor co-activator-3 attenuates carbon tetrachloride-induced murine hepatic injury and fibrosis.Biglycan fragmentation in pathologies associated with extracellular matrix remodeling by matrix metalloproteinases.Liver Fibrosis in HCV Monoinfected and HIV/HCV Coinfected Patients: Dysregulation of Matrix Metalloproteinases (MMPs) and Their Tissue Inhibitors TIMPs and Effect of HCV Protease InhibitorsEffects of hyperinsulinemia on hepatic metalloproteinases and their tissue inhibitors.
P2860
Q26771518-6CF659C5-8E66-4AB5-8E6F-24BAB0E23131Q27011588-A3EE822A-ACCB-4886-8D42-0823E4F4AEFFQ27310099-A03B0000-F280-486F-A03C-6A92315EFEDCQ28477074-7E0AAD39-39AF-4797-A99E-63CFCEE2F516Q28478257-99F82B20-5914-406D-AA16-2CE14C841B17Q33428110-6A4FB4A3-9F3D-489D-8103-2FCB5B0DAB0AQ33575628-353C3D2B-71F1-499C-B22D-5BDDC4830B30Q33587133-2AB9229D-36F3-4BAD-89D6-A5D06A7E4A2FQ33594205-71FE4B02-2FE1-4862-B2E8-2049CC090653Q33622449-3EDD9E61-A0F0-4B0C-9318-E4F37C1F515DQ33744692-37F107B9-9ECE-4B1F-A937-2650F6E003A2Q33802934-7E6B45C5-78FA-43A4-9FC3-84AA62E86E14Q33894802-70C529A8-1129-4B89-B2A0-F5E4D19C56DDQ33976028-6A889A01-672C-4AA2-B9BB-116A0377DE53Q34159587-7221927E-0971-4F83-9DAF-C68F53E2EB43Q34254473-999DAFDE-1E85-432B-BBE4-7F9A4D55140EQ34414424-93BE06A2-D733-4483-A6A6-C4290B1227E3Q34515203-1D382DD2-0FA9-47E9-8619-1AD92613D203Q34542461-07454193-503F-4825-9D92-B25C9281D21CQ34556913-5A1F1045-B861-4564-B7F0-60D04C5B41B6Q34625795-D3000208-31BC-49D7-8DD7-7CB18EB627A3Q34630224-680722CB-2B43-471E-BD37-2688FF7683E6Q35073951-82639C96-D350-4A7C-BA81-6A9524990888Q35126924-C4154E44-15D1-49B1-8C39-B17CA832825FQ35227735-BC524547-2B8A-4A05-A3FF-CB47D46BA6BAQ35477274-F66D369E-2051-4146-A2C7-D86075715FB6Q35622533-A51307EE-A736-4BF5-A590-9D3BCE03A3C5Q35630660-2789AF5E-06AA-44EF-93A4-59F719EE7A71Q35830977-8202A30E-6857-4EED-8D52-C4D337E8FC80Q35884061-85612884-7BFA-47C4-B11D-A9768DFBE4C5Q36175084-6D53BE64-E7AD-4A8C-A617-15BFF45B0CC8Q36383073-18BC40B0-47E4-4D3B-B50B-1B01F76446E0Q36576517-FAE26385-4C90-4E4B-AEB9-1F241EE388F6Q36618918-C146C27E-8E21-4299-8EFA-A843EC2D9E4EQ36672445-4D1E36CF-6377-46F1-90DD-00C99EE0A6E2Q36736678-02A04D28-6644-400F-8E03-62E9306FCF9CQ36749958-7F8EBCC3-DFB6-4A74-9431-C11EFF265C86Q36835374-3387EEDF-ECD0-48D2-8384-CB643AB64AAEQ36846902-E69C9C6C-755C-4846-9C58-A9CB9994E4B7Q36877078-73E326B4-15E7-4816-B290-940792CFC238
P2860
Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Expression of MMPs and TIMPs i ...... s on anti-fibrotic strategies.
@ast
Expression of MMPs and TIMPs i ...... s on anti-fibrotic strategies.
@en
type
label
Expression of MMPs and TIMPs i ...... s on anti-fibrotic strategies.
@ast
Expression of MMPs and TIMPs i ...... s on anti-fibrotic strategies.
@en
prefLabel
Expression of MMPs and TIMPs i ...... s on anti-fibrotic strategies.
@ast
Expression of MMPs and TIMPs i ...... s on anti-fibrotic strategies.
@en
P2093
P1476
Expression of MMPs and TIMPs i ...... s on anti-fibrotic strategies.
@en
P2093
Jürgen Graf
Martin Roderfeld
Stefanie Hemmann
P304
P356
10.1016/J.JHEP.2007.02.003
P577
2007-03-05T00:00:00Z